Search results

Selected filters:

Life Sciences
Analysis

Article type

Topic

Sector

Regions

Year

256 results found for your search

Sort options
18 February 2019

Patent deals show how Indian startups can benefit from multinational research activity

An AI health-tech startup recently named one of the world's most promising had its roots in the re-organisation of Xerox's research centre in India

15 February 2019

AbbVie’s Humira strategy to be scrutinised in first evergreening unclean hands challenge

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug.

14 February 2019

As 101 debate continues, Iancu offers clear message to Federal Circuit

With new guidelines set to reshape patent examination, the USPTO head makes the case for revisiting subject matter precedent

12 February 2019

New investment platform aims to break down barriers to capital for innovators

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative

08 February 2019

The US’s first all biosimilar patent suit shows new pharma IP landscape is emerging

Coherus launched Delaware action against Amgen in what is likely to become an increasingly familiar life sciences litigation scenario.

08 February 2019

US patent system jumps to second in the world, though the biopharma sector may not agree

PTAB reforms help fuel a miraculous rise up the latest International IP Index, but a recent Federal Circuit decision on eligibility highlights the serious challenges that remain - especially for life sciences companies

02 February 2019

Why life sciences companies are falling out of the innovation big leagues

Increased R&D outsourcing and patent licensing account for pharma’s diminishing representation among the world’s top 100 innovators, while technological diversification may also be playing its part

28 January 2019

Critical condition: has Section 101 put the US medical device sector on life support?

As fears grow over subject-matter eligibility and technological convergence threatens to reshape the competitive landscape, patent strategy has become even more crucial for medical device companies

25 January 2019

SCOTUS ruling is a blow to small companies on the frontline of life sciences innovation

The court’s decision in Helsinn Healthcare v Teva Pharmaceutical will disappoint the many biopharma businesses that depend on pre-marketing drug development collaboration

24 January 2019

How <em>Arrow</em> declarations can target a clear path to market 

Given the difficulty that pharmaceutical products face when it comes to reaching market, Arrow declarations can be a crucial means of slicing through the knot.

22 January 2019

Despite its potential appeal to patent owners don’t expect a litigation stampede to Waco

Appointment of experienced patent litigator to local bench and Austin's growing reputation as a tech hub must be weighed against defendant-friendly rules

21 January 2019

New Indian patent office rules set to speed examinations

Draft changes would entitle women inventors and small businesses to expedited patent examination, but some see a backdoor for big business to take advantage too

18 January 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards.

18 January 2019

Downward trend in US patent litigation continues; Big Tech gets busier at the PTAB

Lawsuit filings and inter partes review petitions both fell in 2018, but operating companies’ share of the action was on the rise 

17 January 2019

University domination of the biologics patent landscape points way to heightened deal-making in the coming years

New report shows research institutions dominate the field, with UCAL, Johns Hopkins, Stanford, the NIH, Harvard and Singapore’s Agency for Science Technology & Research leading the way between 2015 and 2018